title: What are the latest recommendations for pneumococcal vaccines?
abstract: The Advisory Committee on Immunization Practices recently updated its guidelines on pneumococcal pneumonia vaccines for older adults. The new guidelines recommend that patients age 65 years and older receive the PCV13 vaccine in a series along with the PPSV23 vaccine. This article summarizes these changes along with a review of when to vaccinate other key adult populations.
authors.affiliation: At the South Carolina College of Pharmacy, University of South Carolina in Charleston, Patricia H. Fabel is a clinical assistant professor and Emily C. Horton is a doctor of pharmacy student. Kayce Shealy is an assistant professor at Presbyterian College School of Pharmacy in Clinton, S.C. The authors have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Patricia H
authors.initials: PH
authors.lastname: Fabel
authors.forename: Emily C
authors.initials: EC
authors.lastname: Horton
authors.forename: Kayce
authors.initials: K
authors.lastname: Shealy
mesh_terms: D026683:Advisory Committees; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000592:standards*; D017410:Practice Guidelines as Topic; D014611:Vaccination / Q000592:standards*
chemical_list: C538862:13-valent pneumococcal vaccine; C414006:23-valent pneumococcal capsular polysaccharide vaccine; D022242:Pneumococcal Vaccines